Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in new therapies and the pipeline indicates this trend will continue. A large range of therapeutic areas from oncology to cardiology have seen rapidly proliferating clinical trials.
Discover the latest advancements and market trends in cell therapy, gene therapy, and RNA therapy with Kalorama Information’s comprehensive report, Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029. Explore how these cutting-edge treatments are revolutionizing healthcare by targeting genetic causes of diseases and harnessing the body’s immune system.
Key Features:
- Market estimates and forecasts from 2023-2029
- Development pipeline analysis
- Competitive landscape assessment
- Detailed chapters on oncology, neurology, musculoskeletal disorders, dermatology, cardiology, and other therapeutic areas
Scope:
- Covers cell therapies, gene therapies, and RNA therapies
- Excludes RNA therapies for COVID-19 and mRNA vaccines
- Does not focus on cord blood products
Forecast:
- Dollar figures represent estimated global market for 2023 and expected market for 2029
- Forecasts provided through 2029, based on manufacturers’ revenues
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Global Cell and Gene Therapy Market, by Product Segment ($ millions)
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR |
| Neurology | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Oncology | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Musculoskeletal | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Dermatology | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Cardio/non-oncology blood | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Other | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
| Total | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | $XX Million | XX% |
Source: Kalorama Information
